[Federal Register Volume 67, Number 16 (Thursday, January 24, 2002)]
[Notices]
[Pages 3494-3495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1793]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Notice of Meeting: Secretary's Advisory Committee on Genetic 
Testing

    Pursuant to Public Law 92-463, notice is hereby given of the 
twelfth meeting of the Secretary's Advisory Committee on Genetic 
Testing (SACGT), U.S. Public Health Service. The meeting will be held 
from 9 a.m. to 5 p.m. on February 13, 2002, and 8:30 a.m. to 5 p.m. on 
February 14, 2002, at the Bethesda Marriott, 5151 Pooks Hill road, 
Bethesda, MD 20814. The meeting will be open to the public with 
attendance limited to space available.

[[Page 3495]]

    The Committee will discuss a number of topics, including a report 
from HHS agencies on their support of activities that increase the 
knowledge and utility of genetic tests, horizon scanning in genetic 
testing, and the Informed Consent Work Group's development of 
principles of informed consent in clinical and public health settings. 
Through a number of invited presentations, the Committee will also 
begin exploring issues regarding the collection and analysis of 
population data by race and ethnicity in health policy generally and in 
genetic testing specifically. Time will be provided for public comment 
and interested individuals should notify the contact person listed 
below.
    Under authority of 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established SACGT to advise and make recommendations to the Secretary 
through the Assistant Secretary for Health on all aspects of the 
development and use of genetic tests. SACGT is directed to (1) 
recommend policies and procedures for the safe and effective 
incorporation of genetic technologies into health care; (2) assess the 
effectiveness of existing and future measures for oversight of genetic 
tests; and (3) identify research needs related to the Committee's 
purview.
    The draft meeting agenda and other information about SACGT will be 
available at the following web site: http://www4.od.nih.gov/oba/sacgt.htm. Individuals who wish to provide public comment or who plan 
to attend the meeting and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify the SACGT Executive Secretary, Ms. Sarah Carr, by telephone at 
301-496-9838 or E-mail at [email protected]. The SACGT office is located 
at 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892.

    Dated: January 15, 2002.
Sarah Carr,
Executive Secretary, SACGT.
[FR Doc. 02-1793 Filed 1-23-02; 8:45 am]
BILLING CODE 4140-01-M